Read + Share
Tripathi C, Tovar Perez JE, Kapoor S, Muhsin A, et al. Antitumor efficacy of intermittent low-dose erlotinib plus sulindac via MHC
upregulation and remodeling of the immune cell niche. Int J Cancer 2025;157:355-370.
PMID: 40072251
|
 |
|
Tripathi C, Tovar Perez JE, Kapoor S, Muhsin A, et al. Antitumor efficacy of intermittent low-dose erlotinib plus sulindac via MHC
upregulation and remodeling of the immune cell niche. Int J Cancer 2025;157:355-370.
PMID: 40072251
|
|
|
|